Ramesh Krishnan, CEO, India operations, Parkway Pantai, on varied strategies that led to re-positioning of Global Hospitals and Continental Hospitals.
Parkway Pantai Limited, a subsidiary of Malaysia’s IHH Berhad Group, has captured a significant pie of the India healthcare market with two back-to back acquisitions in 2015. Asia’s largest healthcare player, Parkway, scooped up 51% stake in Hyderabad’s Continental Hospitals in March, and followed it up with 74% stake in Hyderabad’s Global Hospitals.
The group’s other investments through 50% JV route include the under construction Parkway Khubchandani Hospital in Mumbai, Apollo Gleneagles in Kolkata as well as a PET Centre in Hyderabad in association with Apollo. Parkway also has its indirect presence in India through IHH, which holds 10.85% stake in Apollo Hospitals Enterprises Limited.
Parkway’s current growth strategy in India is revolved around realigning Global and Continental Hospitals as per global standards as well as fortifying the group’s presence in cities where it has its footprint.
Parkway’s expansion plans in India gained momentum, after you joined the group as the head of Middle East and South Asia region. What growth strategy you had in mind, when Parkway set out to acquire projects in India?
Post the IPO, around five years back, Parkway chalked out an array of imperatives that defined its roadmap for India. The Indian healthcare market was poised for rapid growth and Parkway zeroed in on India as a core market in Asia.
The first imperative was not to tread on the Greenfield path. This was based on our experience of inordinate delays and setbacks that impair Greenfield projects in India. The decision was also buoyed by the fact that acquisitions would help us hit the market faster and would be a better vehicle for growth. And, in acquisitions, we decided to forge deals with hold majority stake.
This story is from the September 2016 edition of Healthcare Radius.
Start your 7-day Magzter GOLD free trial to access thousands of curated premium stories, and 9,000+ magazines and newspapers.
Already a subscriber ? Sign In
This story is from the September 2016 edition of Healthcare Radius.
Start your 7-day Magzter GOLD free trial to access thousands of curated premium stories, and 9,000+ magazines and newspapers.
Already a subscriber? Sign In
Centre For Sight forms JV with Laxmi Eye Hospital
Expands in Maharashtra; to collaborate with Laxmi Eye Hospital for local market reach.
Diverse information sources are reshaping treatment patterns - Study
A CLIRNET study finds that doctors exposed to multichannel content, demonstrate a 50 percent higher likelihood of diversifying their treatment patterns.
Advanced test for IRD diagnosis launched
Nucleome Informatics unveils an advanced genetic test for diagnosing inherited retinal diseases (IRDS
A device for facial muscle toning, anti-aging. Interested?
Dr Rickson's Dermatherapie Clinic launches device for facial muscle toning, lifting, tightening, and texture improvement.
Therapeutics startup Wundrsight raises $400K in seed round
Wundrsight secures $400,000 in seed round led by Inflection Point Ventures. The fresh funds will be utilized in development of company's VR-based mental health solutions
Odisha's Komal Panda wins James Dyson award
Komal Panda wins the James Dyson Award 2024 for her innovation for diabetes patients, Novocarry, a portable cooling carrier that helps in keeping insulin under desired temperatures.
REHABILITATION SERVICES: AN EVOLVING LANDSCAPE
India's healthcare rehabilitation services market is rapidly evolving, driven by rising demand and investments.
FIVE CYBERKNIFE RADIOSURGERY BENEFITS IN HEAD AND NECK CANCER TREATMENT
Explore why cyberknife radiosurgery promises to be a game-changer in head and neck cancer treatment by revolutionizing care and improving patient outcomes.
CARING FOR THE ELDERLY
India's aging population presents a pressing need for comprehensive healthcare services. Learn how the country's healthcare system can address this challenge.
TACKLING INDIA'S IMMUNIZATION CHALLENGE
India's vast geography and large population challenge comprehensive immunization. Despite successes in children's immunization, more work is needed. A report.